Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2022 年第 2 季持倉
持倉截至 2022/6/30，2022/8/15 申報。只含多頭部位，變化是跟 2022 年第 1 季比股數。
- 持股檔數
- 109
- 較 2022 年第 1 季 −26
- 總值
- $31.8 億
- 較 2022 年第 1 季 −$16.3 億 (−33.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $4.56 億 | 14.3% | – | – | – |
| FOLDAmicus Therapeutics, Inc. | COM | 26,895,532 | $2.89 億 | 9.1% | −660,313−2.4% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 2,866,863 | $1.92 億 | 6.0% | +486,153+20.4% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,086,727 | $1.34 億 | 4.2% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,826,299 | $1.31 億 | 4.1% | −374,962−3.1% | 減碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 56,560,211 | $1.22 億 | 3.8% | +240,251+0.4% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 5,321,032 | $9,924 萬 | 3.1% | +157,515+3.1% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 3,015,054 | $9,633 萬 | 3.0% | −877,439−22.5% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,867,446 | $9,522 萬 | 3.0% | −660,547−14.6% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 3,540,408 | $6,819 萬 | 2.1% | +2,066,301+140.2% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,122,535 | $6,457 萬 | 2.0% | −288,912−12.0% | 減碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,963,277 | $5,271 萬 | 1.7% | +15,000+0.2% | 加碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 9,146,730 | $5,168 萬 | 1.6% | +5,924,170+183.8% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 5,534,169 | $5,114 萬 | 1.6% | −2,602,461−32.0% | 減碼 | – |
| RXDXPrometheus Biosciences, Inc. | COM | 1,682,242 | $4,749 萬 | 1.5% | −758,340−31.1% | 減碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $4,687 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 2,319,117 | $4,369 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM NEW | 52,335,002 | $4,231 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| SGENSeagen Inc. | COM | 224,000 | $3,964 萬 | 1.2% | +224,000 | 新進 | 歷史 |
| VERUVeru Inc. | COM | 3,500,000 | $3,955 萬 | 1.2% | −861,998−19.8% | 減碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,903,879 | $3,952 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 397,888 | $3,879 萬 | 1.2% | +2,249+0.6% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,913,791 | $3,493 萬 | 1.1% | −886,171−31.6% | 減碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $3,255 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| LLYEli Lilly & Co | Stock | 100,000 | $3,242 萬 | 1.0% | +100,000 | 新進 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $2,948 萬 | 0.9% | – | – | – |
| COGTCogent Biosciences, Inc. | COM | 3,088,972 | $2,786 萬 | 0.9% | −99,778−3.1% | 減碼 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 3,645,471 | $2,639 萬 | 0.8% | −1,050,377−22.4% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 367,501 | $2,631 萬 | 0.8% | +89,215+32.1% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 172,991 | $2,523 萬 | 0.8% | −7,088−3.9% | 減碼 | 歷史 |
| PRCTPROCEPT BioRobotics Corp | COM | 749,700 | $2,451 萬 | 0.8% | −738,584−49.6% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 9,111,151 | $2,451 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 11,521,102 | $2,281 萬 | 0.7% | −412,285−3.5% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,655,007 | $2,244 萬 | 0.7% | −96,594−5.5% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 405,759 | $2,207 萬 | 0.7% | −44,615−9.9% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 4,132,534 | $2,190 萬 | 0.7% | −1,193,081−22.4% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 2,500,000 | $2,178 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 1,914,592 | $2,173 萬 | 0.7% | +133,357+7.5% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 1,141,990 | $2,065 萬 | 0.6% | +1,141,990 | 新進 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 2,087,956 | $2,009 萬 | 0.6% | −3,137,459−60.0% | 減碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 411,804 | $2,008 萬 | 0.6% | +411,804 | 新進 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $1,893 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| AORTArtivion, Inc. | COM | 929,705 | $1,755 萬 | 0.6% | +314,002+51.0% | 加碼 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 1,051,904 | $1,633 萬 | 0.5% | −463,457−30.6% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,166,883 | $1,606 萬 | 0.5% | −511,207−30.5% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,697,033 | $1,541 萬 | 0.5% | −2,142,347−55.8% | 減碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 180,000 | $1,492 萬 | 0.5% | +180,000 | 新進 | 歷史 |
| OMOutset Medical, Inc. | COM | 998,727 | $1,484 萬 | 0.5% | −884,672−47.0% | 減碼 | 歷史 |
| LONALeonaBio, Inc. | COM | 4,797,278 | $1,463 萬 | 0.5% | +1,371,362+40.0% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 321,300 | $1,453 萬 | 0.5% | −1,160,400−78.3% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 570,084 | $1,381 萬 | 0.4% | −1,275,471−69.1% | 減碼 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 2,483,619 | $1,381 萬 | 0.4% | 00.0% | 不變 | – |
| OMICSingular Genomics Systems, Inc. | COM | 3,536,274 | $1,351 萬 | 0.4% | −118,933−3.3% | 減碼 | 歷史 |
| TMCITreace Medical Concepts, Inc. | COM | 941,192 | $1,350 萬 | 0.4% | −30,000−3.1% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,915,146 | $1,221 萬 | 0.4% | −129,157−4.2% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 971,832 | $1,124 萬 | 0.4% | −451,221−31.7% | 減碼 | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 441,680 | $1,095 萬 | 0.3% | −1,213,399−73.3% | 減碼 | – |
| CMAXCareMax, Inc. | COM CL A | 3,000,000 | $1,089 萬 | 0.3% | −186,663−5.9% | 減碼 | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $1,082 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 556,047 | $995.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM | 5,038,983 | $967.5 萬 | 0.3% | +1,428,571+39.6% | 加碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 7,951,448 | $914.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,150,641 | $905.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ISOIsoPlexis Corp | COM | 4,095,498 | $884.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,421,142 | $881.2 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HLVXHilleVax, Inc. | COM | 764,907 | $836.0 萬 | 0.3% | +764,907 | 新進 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $825.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 273,423 | $796.2 萬 | 0.3% | +60,000+28.1% | 加碼 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 572,514 | $791.2 萬 | 0.2% | +435,000+316.3% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 363,197 | $788.1 萬 | 0.2% | −404,130−52.7% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 1,073,995 | $731.4 萬 | 0.2% | −120,000−10.1% | 減碼 | 歷史 |
| SLGCSomaLogic, Inc. | CLASS A COM | 1,500,000 | $678.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HCATHealth Catalyst, Inc. | COM | 465,162 | $674.0 萬 | 0.2% | −28,500−5.8% | 減碼 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 5,000,000 | $630.0 萬 | 0.2% | +2,500,000+100.0% | 加碼 | 歷史 |
| ICVXIcosavax, Inc. | COM | 1,042,850 | $597.6 萬 | 0.2% | −336,287−24.4% | 減碼 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 766,231 | $577.7 萬 | 0.2% | −1,316,492−63.2% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 1,769,701 | $573.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ATNXAthenex, Inc. | COM | 13,532,467 | $554.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 341,239 | $476.4 萬 | 0.1% | −42,000−11.0% | 減碼 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $402.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| QTNTQuotient Ltd | SHS | 16,200,818 | $388.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,281,197 | $384.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,528,812 | $363.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MGNXMacrogenics Inc | COM | 1,227,202 | $362.0 萬 | 0.1% | −332,587−21.3% | 減碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 494,403 | $353.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $321.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 212,018 | $320.8 萬 | 0.1% | +212,018 | 新進 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 1,500,000 | $301.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ABSIAbsci Corp | COM | 894,346 | $296.9 萬 | 0.1% | −296,606−24.9% | 減碼 | 歷史 |
| NVNOenVVeno Medical Corp | COMMON STOCK | 781,615 | $295.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,052,445 | $262.1 萬 | 0.1% | −174,572−14.2% | 減碼 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,134,388 | $253.0 萬 | 0.1% | −365,612−24.4% | 減碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 508,532 | $239.0 萬 | 0.1% | −88,410−14.8% | 減碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 121,350 | $230.4 萬 | 0.1% | −30,000−19.8% | 減碼 | 歷史 |
| DRIODarioHealth Corp. | COM NEW | 327,869 | $201.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 294,118 | $144.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| PEARPear Therapeutics, Inc. | CLASS A COM | 900,548 | $138.6 萬 | <0.1% | −25,684−2.8% | 減碼 | 歷史 |
| RACEFerrari N.V. | COM | 6,200 | $113.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SONXSonendo, Inc. | COM | 648,505 | $111.5 萬 | <0.1% | −20,000−3.0% | 減碼 | 歷史 |
| ZYZymergen Inc. | COM | 883,332 | $108.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $742.7 萬 | – |
| FLNAFilana Therapeutics, Inc. | COM | $281.2 萬 | – |
2022 年第 1 季之後清倉（33 檔）
2022 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 1 季股數 | 2022 年第 1 季市值 | 2022 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,357,903 | $1.43 億 | 3.0% | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $8,947 萬 | 1.9% | – |
| NVRONevro Corp | COM | 477,037 | $3,450 萬 | 0.7% | 歷史 |
| PENPenumbra Inc | COM | 143,591 | $3,190 萬 | 0.7% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 501,509 | $2,314 萬 | 0.5% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 616,141 | $2,239 萬 | 0.5% | 歷史 |
| AXNXAxonics, Inc. | COM | 341,211 | $2,136 萬 | 0.4% | 歷史 |
| LUNGPulmonx Corp | COM | 537,779 | $1,334 萬 | 0.3% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 405,000 | $1,278 萬 | 0.3% | 歷史 |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $1,104 萬 | 0.2% | – |
| HLTHCue Health Inc. | COM | 1,580,607 | $1,020 萬 | 0.2% | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 1,000,000 | $987.0 萬 | 0.2% | – |
| Summit Healthcre Acquistn CoG8566R128 | UNIT 06/03/2026 | 1,000,000 | $977.7 萬 | 0.2% | – |
| RACBResearch Alliance Corp. II | COM CL A | 1,000,000 | $976.0 萬 | 0.2% | 歷史 |
| EVHEvolent Health, Inc. | CL A | 250,000 | $807.5 萬 | 0.2% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 284,853 | $689.9 萬 | 0.1% | 歷史 |
| ACCDAccolade, Inc. | COM | 330,682 | $580.7 萬 | 0.1% | 歷史 |
| MRUSMerus N.V. | COM | 209,046 | $552.7 萬 | 0.1% | 歷史 |
| DALSDA32 Life Science Tech Acquisition Corp. | CLASS A COM | 500,000 | $485.8 萬 | 0.1% | 歷史 |
| SGHTSight Sciences, Inc. | COM | 390,000 | $450.8 萬 | 0.1% | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 450,000 | $446.0 萬 | 0.1% | 歷史 |
| NVTAInvitae Corp | COM | 554,585 | $442.0 萬 | 0.1% | 歷史 |
| IMRXImmuneering Corp | CLASS A COM | 681,051 | $440.6 萬 | 0.1% | 歷史 |
| NARIInari Medical, Inc. | Stock | 30,000 | $271.9 萬 | 0.1% | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 65,144 | $238.2 萬 | <0.1% | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 325,854 | $166.2 萬 | <0.1% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 44,475 | $145.7 萬 | <0.1% | 歷史 |
| ONCROncorus, Inc. | COM | 752,241 | $133.9 萬 | <0.1% | 歷史 |
| RPIDRapid Micro Biosystems, Inc. | CLASS A COM | 190,745 | $129.5 萬 | <0.1% | 歷史 |
| Rockley Photonics Holdings LG7614L117 | *W EXP 08/11/202 | 500,000 | $42.5 萬 | <0.1% | – |
| Butterfly Network, Inc.124155110 | *W EXP 05/27/202 | 233,333 | $23.8 萬 | <0.1% | – |
| SLGCWSomaLogic, Inc. | *W EXP 03/01/202 | 110,000 | $23.5 萬 | <0.1% | 歷史 |
| UTRSMinerva Surgical Inc | COM | 50,268 | $22.6 萬 | <0.1% | 歷史 |